文献速递生殖医学

MEIOSIN纯合错义变异通过影响减数分裂起始导致早发性卵巢功能不全

Homozygous missense variant in MEIOSIN causes premature ovarian insufficiency.
PubMed 文献 · Hum Reprod · 2023-01-01

该回顾性遗传学研究在1030例特发性早发性卵巢功能不全(POI)患者的外显子组测序数据库中筛查减数分裂起始基因变异,发现一例患者携带MEIOSIN纯合变异c.1735C>T(p.R579W)。体外实验和点突变小鼠模型证实该变异损害MEIOSIN转录激活减数分裂基因的功能,影响减数分裂前期I程序并加速卵母细胞耗竭,提示MEIOSIN变异以隐性模式参与人类POI的发病。

要点

  • 在1030例特发性POI患者中鉴定出MEIOSIN纯合错义变异c.1735C>T(p.R579W)。
  • 双荧光素酶报告实验显示该变异削弱MEIOSIN上调减数分裂基因的转录功能。
  • 同源突变敲入小鼠证实该变异影响减数分裂前期I程序并加速卵母细胞耗竭。

核心结论

  • MEIOSIN变异通过损害减数分裂基因的转录调控导致POI,并以隐性模式遗传。
  • 本研究扩展了对MEIOSIN蛋白HMG框结构域功能的认识。
  • 尽管减数分裂起始基因的致病性变异在POI中罕见,本研究证实了一个MEIOSIN变异的致病性并阐明了人类不孕的另一种机制。

研究设计与样本

  • 回顾性遗传学研究,筛查1030例特发性POI患者院内全外显子组测序(WES)数据库中减数分裂起始基因的纯合或复合杂合变异。
  • 通过体外实验(蛋白结构预测和双荧光素酶报告实验)验证变异致病性,并通过点突变小鼠模型的组织学分析展示变异对卵巢功能和减数分裂的影响。

主要发现

  • 在一例特发性POI患者中分别鉴定出MEIOSIN纯合变异c.1735C>T(p.R579W)和STRA8变异c.258+1G>A,后者已在近期发表的工作中报道。
  • 双荧光素酶报告实验显示MEIOSIN变异不利于其上调减数分裂基因的转录功能。
  • 同源突变敲入小鼠证实该变异影响减数分裂前期I程序并加速卵母细胞耗竭。
  • 变异p.R579W位于高迁移率族(HMG)框结构域,破坏MEIOSIN蛋白的核定位,但对卵母细胞的细胞周期转换并非必需,提示MEIOSIN HMG框结构域在减数分裂起始中的独特作用。

局限性

  • 需要进一步研究以探索其他减数分裂起始基因在POI发病中的作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Are variants of genes involved in meiosis initiation responsible for premature ovarian insufficiency (POI)? SUMMARY ANSWER: A MEIOSIN variant participates in the pathogenesis of human POI by impairing meiosis due to insufficient transcriptional activation of essential meiotic genes. WHAT IS KNOWN ALREADY: Meiosis is the key event for the establishment of the ovarian reserve, and several gene defects impairing meiotic homologous recombination have been found to contribute to the pathogenesis of POI. Although STRA8 and MEIOISN variants have been found to associate with POI in a recent study, the condition of other meiosis initiation genes is unknown and direct evidence of variants participating in the pathogenesis of POI is still lacking. STUDY DESIGN, SIZE, DURATION: This was a retrospective genetic study. An in-house whole exome sequencing (WES) database of 1030 idiopathic POI patients was screened for variations of meiosis initiation genes. PARTICIPANTS/MATERIALS, SETTING, METHODS: Homozygous or compound heterozygous variations of genes involved in meiosis initiation were screened in the in-house WES database. The pathogenicity of the variation was verified by in vitro experiments, including protein structure prediction and dual-luciferase reporter assay. The effect of the variant on ovarian function and meiosis was demonstrated through histological analyses in a point mutation mouse model. MAIN RESULTS AND THE ROLE OF CHANCE: One homozygous variant in MEIOSIN (c.1735C>T, p.R579W) and one in STRA8 (c.258 + 1G>A), which initiates meiosis via the retinoic acid-dependent pathway, were identified in a patient with idiopathic POI respectively. The STRA8 variation has been reported in the recently published work. For the MEIOSIN variation, the dual-luciferase reporter assay revealed that the variant adversely affected the transcriptional function of MEIOSIN in upregulating meiotic genes. Furthermore, knock-in mice with the homologous mutation confirmed that the variation impacted the meiotic prophase I program and accelerated oocyte depletion. Moreover, the variant p.R579W localizing in the high-mobility group (HMG) box domain disrupted the nuclear localization of the MEIOSIN protein but was dispensable for the cell-cycle switch of oocytes, suggesting a unique role of the MEIOSIN HMG box domain in meiosis initiation. LIMITATIONS, REASONS FOR CAUTION: Further studies are needed to explore the role of other meiosis initiation genes in the pathogenesis of POI. WIDER IMPLICATIONS OF THE FINDINGS: The MEIOSIN variant was verified to cause POI by impaired transcriptional regulation of meiotic genes and was inherited by a recessive mode. The function of HMG box domain in MEIOSIN protein was also expanded by this study. Although causative variations in meiotic initiation genes are rare in POI, our study confirmed the pathogenicity of a MEIOSIN variant and elucidated another mechanism of human infertility. STUDY FUNDING/COMPETING INTEREST(S): This work was supported by the National Key Research & Developmental Program of China (2022YFC2703800, 2022YFC2703000), National Natural Science Foundation for Distinguished Young Scholars (82125014), National Natural Science Foundation of China (32070847, 32170867, 82071609), Basic Science Center Program of NSFC (31988101), Natural Science Foundation of Shandong Province for Grand Basic Projects (ZR2021ZD33), Natural Science Foundation of Shandong Province for Excellent Young Scholars (ZR2022YQ69), Taishan Scholars Program for Young Experts of Shandong Province (tsqn202211371), and Qilu Young Scholars Program of Shandong University. The authors declare no conflict of interest. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Zhang Q, Zhang W, Wu X, et al. Homozygous missense variant in MEIOSIN causes premature ovarian insufficiency. Hum Reprod. 2023. PMID: 37982418. doi:10.1093/humrep/dead084

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。